Anaemia of prematurity. Anaemia of prematurity
Conditions
Interventions
Intervention 1: Infants in control group don’t receive placebo. Control infants receive 3 mg/kg/day elemental iron once a day enterally. In all infants minimal the enteral intake at the end of first w
Prevention
Infants in control group don’t receive placebo. Control infants receive 3 mg/kg/day elemental iron once a day enterally. In all infants minimal the enteral intake at the end of first week of age is 50
Treated infants receive 500 u/kg/wk rhu EPO, 2 times weekly, administer subcutaneously in lateral side of thight. Treatment continue untile 4 weeks after beginning. Criteria for withholding / stopping
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: premature infants with birth weight 40% head box oxygen or dependent on mechanical ventilation, systolic blood pressure > 100mm Hg , an absolute neutrophil counts (ANC) of = 500/µl.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematocrit. Timepoint: at the beginning and end of study. Method of measurement: with colter counter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pack cell transfusion. Timepoint: at the end of study. Method of measurement: ml.;Ferritin. Timepoint: begining and end of study. Method of measurement: Radioimunoassay.;Reticulocyte. Timepoint: begining and end of study. Method of measurement: Microscope.;Mean daily weight gain. Timepoint: begining and end of study. Method of measurement: Weigher. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNoori-Shakam M.
Kerman University of Medical Sciences
Outcome results
None listed